Recent research has shown the PI3K/AKT/mTOR pathway to be activated in gastric cancer and that activation of this pathway correlated with metastasis, poor prognosis, and reduced survival of gastric cancer patients [34]. This evidence concerns the gene AKT1 and gastric cancer.